Ken Griffin's position in Abbott Laboratories is currently worth $191 Million. That's 0.21% of their equity portfolio (88th largest holding). The first Abbott Laboratories trade was made in Q2 2013. Since then Ken Griffin bought shares 48 more times and sold shares on 42 occasions. The stake costed the investor $165 Million, netting the investor a gain of 16% so far.